These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 8661952
41. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. Cross NA, Hillman LS, Allen SH, Krause GF. J Bone Miner Res; 1995 Sep; 10(9):1312-20. PubMed ID: 7502702 [Abstract] [Full Text] [Related]
42. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G. J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196 [Abstract] [Full Text] [Related]
43. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. Thiébaud D, Burckhardt P, Kriegbaum H, Huss H, Mulder H, Juttmann JR, Schöter KH. Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122 [Abstract] [Full Text] [Related]
44. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]. Matuszkiewicz-Rowińska J, Niemczyk S, Przedlacki J, Puka J, Switalski M, Ostrowski K. Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839 [Abstract] [Full Text] [Related]
45. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H, Risedronate Phase III Research Group. Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940 [Abstract] [Full Text] [Related]
46. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T. J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511 [Abstract] [Full Text] [Related]
47. Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model. Chou FF, Huang SC, Chen SS, Wang PW, Huang PH, Lu KY. Osteoporos Int; 2006 Mar; 17(6):936-41. PubMed ID: 16596462 [Abstract] [Full Text] [Related]
48. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. Abe Y, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K. Clin Endocrinol (Oxf); 2000 Feb; 52(2):203-9. PubMed ID: 10671948 [Abstract] [Full Text] [Related]
49. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats. Shiraishi A, Ito M, Hayakawa N, Kubota N, Kubodera N, Ogata E. Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749 [Abstract] [Full Text] [Related]
50. [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats]. Wu MS, Zhao SZ, Ren LZ, Wang R, Bai X, Han HW, Li B. Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2163-8. PubMed ID: 24079247 [Abstract] [Full Text] [Related]
51. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008 [Abstract] [Full Text] [Related]
52. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin. Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M. Osteoporos Int; 1999 Aug; 10(2):128-36. PubMed ID: 10501793 [Abstract] [Full Text] [Related]
53. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L. Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256 [Abstract] [Full Text] [Related]
59. The effect of human-like collagen calcium complex on osteoporosis mice. Zhu C, Lei H, Wang S, Duan Z, Fu R, Deng J, Fan D, Lv X. Mater Sci Eng C Mater Biol Appl; 2018 Dec 01; 93():630-639. PubMed ID: 30274096 [Abstract] [Full Text] [Related]
60. [Effects of calcium supplementation using AAACa or milk on nocturnal bone resorption in young women]. Ohgitani S, Fujii Y, Fujita T. Nihon Ronen Igakkai Zasshi; 1997 Sep 01; 34(9):743-7. PubMed ID: 9430987 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]